Structure–Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties-Reference-Cited by-同舟云学术

Structure–Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties

Published:2023-09-27 Issue:19 Volume:66 Page:13516-13529
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Tsuji Kohei¹^ORCID,Ishii Takahiro¹^ORCID,Kobayakawa Takuya¹,Higashi-Kuwata Nobuyo²,Shinohara Kouki¹,Azuma Chika¹,Miura Yutaro¹,Nakano Hiroki¹,Wada Naoya¹,Hattori Shin-ichiro²,Bulut Haydar³^ORCID,Mitsuya Hiroaki²³⁴,Tamamura Hirokazu¹^ORCID

Affiliation:

1. Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Chiyoda-ku, Tokyo 101-0062, Japan

2. Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Shinjuku-ku, Tokyo 162-8655, Japan

3. Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States

4. Department of Clinical Sciences, Kumamoto University Hospital, Chuo-ku, Kumamoto 860-8556, Japan

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00777

Reference56 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019